More than 90% of patients with systemic mastocytosis have a gain-of-function mutation in codon 816 of the receptor tyrosine kinase KIT, where a valine is substituted for an aspartate (KIT D816V) [5]. The gene discussed is KIT; the disease is systemic mastocytosis.